Pharma & Biotech

The biotechnology landscape has witnessed the emergence of a formidable new contender. Arcutis Biotherapeutics has not only delivered an earnings...

The independent journey of biotechnology firm 2Seventy Bio has concluded following its full acquisition by pharmaceutical giant Bristol Myers Squibb....

Biopharmaceutical company Nuvalent is experiencing a significant market rally, driven by encouraging clinical trial data and regulatory progress within its...

Kura Oncology shares have experienced a dramatic upward movement, capturing significant market attention as investors anticipate a pivotal regulatory review...

Investors are preparing for a pivotal week for BioNTech shares, with the company's third-quarter 2025 financial report scheduled for release...

Revolution Medicines is capturing significant investor attention following two substantial developments that underscore its growing prominence in oncology therapeutics. The...

Investors in Sarepta Therapeutics are approaching the company's upcoming quarterly report with heightened anticipation. The biotech firm's shares recently climbed...

The biotechnology company aTyr Pharma is confronting a significant legal challenge as multiple investor law firms have initiated class action...

Biotechnology leader Amgen finds itself at a critical juncture. The company recently secured a major legal victory that clears a...

While Thermo Fisher Scientific's latest earnings report delivered a powerful performance that delighted the market, the company's strategic direction is...